Lynne Milgram
Internal Medicine · San Diego, CANPI 1629016316
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $89,677 of the $142,615 with a category attached, or 62.9%. It is spread thinly across 32 manufacturers, the largest accounting for just 13.4%. Reporting peaked in 2019 at $43,122 and has fallen 94.2% since, to $2,508 in 2025. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 132 payments — averaging $1080.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$19K
- Pfizer$18K
- Sanofi$14K
- EMD Serono, Inc.$13K
- Boehringer Ingelheim$11K
- Johnson & Johnson$9K
- plus $58K from 26 others
Across 1 payment — averaging $1150.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Viiv Healthcare Company$1K
What the payments were for
- Consulting fees$89,67763%
- Speaking & faculty fees$43,73031%
- Travel & lodging$6,5635%
- Food & beverage$2,5792%
- Education$660%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 20 | $19,054 |
| Pfizer(2 entities) | 16 | $17,838 |
| Sanofi | 2 | $14,490 |
| EMD Serono, Inc. | 14 | $12,924 |
| Boehringer Ingelheim | 11 | $10,704 |
| Johnson & Johnson(3 entities) | 10 | $9,111 |
| Amgen | 4 | $7,900 |
| Vertex | 6 | $5,400 |
| MDD US Operations, LLC | 2 | $4,750 |
| GSK | 3 | $4,745 |
| Gilead | 1 | $4,300 |
| Supernus Pharmaceuticals, Inc. | 4 | $3,643 |
| Amarin Pharma, Inc. | 2 | $3,500 |
| Acadia Pharmaceuticals Inc | 3 | $2,800 |
| Hologic Sales And Service, LLC | 1 | $2,500 |
| Hologic Inc | 8 | $2,395 |
| Novo Nordisk | 1 | $2,355 |
| H. Lundbeck A S | 1 | $2,125 |
| Gen-probe, Inc. | 2 | $2,077 |
| Biogen | 1 | $1,960 |
| Bioventus LLC | 1 | $1,750 |
| Regeneron Healthcare Solutions, Inc. | 1 | $1,625 |
| CSL Behring | 1 | $1,600 |
| Abbott | 1 | $1,375 |
| Optinose US, Inc. | 9 | $1,051 |
| BD | 1 | $350 |
| Centinel Spine, LLC | 1 | $125 |
| UCB, Inc. | 1 | $53 |
| E.r. Squibb & Sons, L.L.C. | 1 | $40 |
| Novartis | 1 | $29 |
| AstraZeneca | 1 | $28 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$14,490
- JARDIANCE$9,272
- BAVENCIO$8,459
- Blincyto$7,800
- SIMPONI ARIA$4,583
- STELARA$4,583
- Yescarta$4,300
- Ponvory$4,290
- QELBREE$3,643
- Vascepa$3,500
- ELIQUIS$2,800
- BENLYSTA$1,825
- Lucemyra/Lofexidine$1,750
- Durolane$1,750
- NUPLAZID$1,750
- EYLEA$1,625
- EUCRISA$1,400
- Alinity i-STAT TBI Plasma test$1,375
- DISEASE EDUCATION$1,050
- Xhance$793
How this compares
$142,615 in reported general payments places this provider in the 95th percentile of 13,581 internal medicine providers in California.
Other internal medicine in San Diego
- Hatim HusainSan Diego$2M
- Steven EdelmanSan Diego$863K
- Christian RamersSan Diego$675K
- Adam ZweigSan Diego$421K
- James BreitmeyerSan Diego$227K
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Teck LingPalo Alto$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.